BDBM179979 US9669095, 13

SMILES CC[C@@H]1NC(=O)[C@@H]2C(ON2C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](NC(=O)[C@@H](N(C)C(=O)[C@@H](C)N(C)C1=O)C(C)(C)CN(C)C(=O)NS(C)(=O)=O)C(C)C)[C@H](C)C\C=C\C

InChI Key InChIKey=RRAIIDJXJMAMAF-AKIUKFHPSA-N

Data  1 EC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 179979   

TargetGenome polyprotein(Hepatitis C virus (HCV genotype 1a, isolate H))
Enanta Pharmaceuticals

US Patent
LigandPNGBDBM179979(US9669095, 13)
Affinity DataEC50:  550nMT: 2°CAssay Description:Briefly, replicon cells are seeded at 7,000 cells per well in 90 ul DMEM (without phenol red, Invitrogen Cat. #31053-036) per well with 10% FCS, 1% n...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent